Drug Monitoring Webinar: Presumptive vs Definitive Drug Testing: What Are We Missing?

The objectives of this webinar include:

 

  - Learn why, now more than ever, drug testing

     needs to be incorporated into the standard of

     clinical care when prescribing controlled

     substances and assessing patients for

     medication adherence or drug misuse 

 

  - Gain a deeper understanding of the differences

     between presumptive and definitive drug

     testing

 

  - Hear results from a recent Quest Diagnostics

     study using national data, which demonstrate

     some of the risks of relying solely on

     point-of-care presumptive testing as a drug

     monitoring solution

Date:

Sep 21, 2021

Location:

Now only as on-demand webinar

Presenter(s):

Jack Kain, PharmD, Les Edinboro, PhD, Executive Science  Director, Toxicology, Quest Diagnostics

Moderator(s):

Jeff Gudin, MD, Senior Medical Advisor, Drug Monitoring and  Toxicology, Quest Diagnostics